Related by context. All words. (Click for frequent words.) 64 Factor VIIa 63 preclinical efficacy 63 isoform selective 63 potent antiproliferative 63 Onconase 63 anti CD3 62 Factor VIIa inhibitor 62 vascular disrupting agents 62 humanized monoclonal 62 therapeutic monoclonal antibody 61 Bruton tyrosine kinase Btk 61 siRNA therapeutic 61 histone deacetylase HDAC inhibitor 61 aurora kinase inhibitor 61 OvaRex R 61 small molecule tyrosine 61 pan HDAC inhibitor 61 indibulin 61 immune modulating 61 GLP toxicology studies 61 novel peptide 61 histone deacetylase HDAC 61 vascular disrupting agent 61 liposomal formulation 60 maturation inhibitor 60 Anavex #-# 60 rxRNA 60 vidofludimus 60 Panzem R NCD 60 novel histone deacetylase 60 torezolid 60 siRNAs targeting 60 KSP inhibitor 60 irreversible inhibitor 60 interferon lambda 60 CCX# 60 tkRNAi technology 59 PI3K/mTOR 59 PDE4 inhibitor 59 nanopharmaceutical 59 p# inhibitor 59 chimeric monoclonal antibody 59 orally administered inhibitor 59 mediated inhibition 59 peptidomimetic 59 PEGylated interferon 59 Squalamine 59 HDAC Inhibitor 59 selective antagonist 59 potently inhibited 59 compound AEZS 59 Annexin V 59 Bruton tyrosine kinase 59 PDE# inhibitors 59 immunotherapeutic vaccine 59 peptidic 58 anti angiogenic agent 58 oral prodrug 58 PORxin TM 58 RNA antagonist 58 histone deacetylase inhibitor 58 polymerase inhibitor 58 CCR5 antagonist 58 CRLX# 58 CCR1 58 mTOR inhibitors 58 ENMD # 58 5 HT2C 58 Trofex 58 ON #.Na 58 Phase 1a clinical 58 selective adenosine 58 JAK2 inhibitor 58 isotype 58 vinca alkaloid 58 peptide conjugated 58 HCV polymerase 58 huN# DM1 58 CCR2 58 JAK inhibitor 58 Protein Kinase C 58 CG# [003] 58 antimitotic 58 siRNA duplexes 58 small molecule activators 58 selective agonist 58 ghrelin antagonist 58 obatoclax 58 novel immunotherapeutic 58 polyclonal antibody 58 Cathepsin S 58 DNA intercalator 58 liposome formulation 58 Anticalins ® 58 Aurora Kinase 57 tkRNAi 57 Angiocept 57 IKK epsilon 57 ALN HTT 57 mGluR2 NAM 57 PI3K/Akt pathway inhibitor 57 HDACi 57 selectively inhibits 57 histamine dihydrochloride 57 Bevasiranib 57 thrombin receptor 57 orally dosed 57 fosbretabulin 57 Marqibo TM 57 cleavable linker 57 DXL# 57 MorphoSys proprietary 57 genomic biomarker 57 DiLA2 liposomes 57 PTK# 57 NEUGENE R 57 AMPK activators 57 Initiates Clinical 57 non nucleoside HCV 57 depsipeptide 57 topoisomerase II inhibitor 57 PEG SN# 57 Davanat 57 Triapine R 57 HCV polymerase inhibitor 57 Guanilib 57 Kahalalide F 57 PSMA ADC 57 busulfan 57 Aplidin 57 Anticalin ® 57 MEK inhibitors 57 NS5B 57 Tarvacin 57 OHR/AVR# 57 Histone deacetylase 57 Cloretazine 57 antisense inhibitor 57 oral tyrosine kinase 57 selective inhibitor 57 beta secretase inhibitor 57 isatoribine 57 HCV NS3 protease 57 JAK#/JAK# 57 Pathway Inhibitor 56 potently inhibits 56 Solazed 56 MAb 56 Nanobody 56 BrachySil TM 56 TRO# 56 PEP# [003] 56 vivo potency 56 humanized monoclonal antibodies 56 TLR8 agonist 56 S#P# 56 Interferon beta 56 mda 7 56 therapeutically relevant 56 CRMD# 56 OXi# 56 HSP# inhibitor 56 Telatinib 56 bazedoxifene selective estrogen receptor 56 CTx 56 OVATURE 56 lipopeptide 56 chemokine receptor 56 preclinically 56 antiapoptotic 56 tubulin inhibitor 56 Monoclonal antibody 56 thalidomide Thalomid 56 mouse xenograft models 56 kinase inhibition 56 ART# 56 HDL Selective Delipidation 56 novel orally bioavailable 56 TKM ApoB 56 vitamin D analogs 56 MEK inhibitor 56 NEUGENE antisense 56 MAGE A3 ASCI 56 selective kinase inhibitor 56 Degarelix 56 HDL Mimetic Peptide 56 Hsp# Inhibitor 56 receptor monoclonal antibody 56 Anticalins R 56 muscarinic 56 Phase #b/#a clinical 56 Phase IIb clinical trials 56 DepoVax 56 bicyclic 56 targeted antifolate 56 HepDirect prodrug 56 SMT C# 56 selective orally bioavailable 56 antiangiogenic agent 56 chemosensitivity 56 anti CD3 monoclonal 56 non nucleoside inhibitor 56 cytoprotective 56 mTOR inhibition 56 Maribavir 56 A3 adenosine receptor 56 ATL# [001] 56 humanized monoclonal antibody 56 demonstrated antitumor activity 56 resolvin 56 GRNVAC1 56 mitogen activated ERK kinase 56 Archexin 56 DermaVir Patch 56 Alfacell proprietary ribonuclease 56 synthetic siRNA 56 Orally administered 56 Curaxin 56 atacicept 56 ESBA# 56 phosphatidylserine PS targeting 56 SNS# T 56 JVRS 56 highly selective inhibitor 56 Interferon alfa 56 aurora kinase 56 AFFiRiS 55 ARRY # 55 oral JAK1 55 Interferon alpha 55 radiolabelled 55 Liposomal 55 generation purine nucleoside 55 tumorigenicity 55 tumor antigen 55 Fc fusion protein 55 nucleotide analog 55 IMiDs R 55 solithromycin 55 epothilones 55 uricase 55 VitiGam TM 55 metabolite identification 55 selective inhibition 55 therapeutic modality 55 cationic lipid 55 AVI NEUGENE 55 Cyclosert 55 Kinase Inhibitor 55 Tarceva TM 55 MoxDuo ® 55 radiolabeled 55 Reports Preclinical Data 55 annexin 55 renin inhibitor 55 adenoviral 55 5 HT4 receptor 55 BAL# [001] 55 Apoptone 55 alkylating agent 55 NPC 1C 55 preclinical pharmacokinetic 55 plasmid DNA vaccine 55 Allovectin 7 55 receptor tyrosine kinase inhibitor 55 Temsirolimus 55 Posiphen TM 55 histone deacetylase 55 antitumoral 55 tumor vascular disrupting 55 HQK 55 MGd 55 ddRNAi 55 Nanobodies 55 cytotoxic T lymphocyte 55 Cyclosporin 55 EndoTAG TM 55 BiTE 55 ARIKACE ™ 55 Immunohistochemical staining 55 Preclinical studies suggest 55 Akt inhibitor 55 volociximab 55 systemic RNAi 55 Anticalin 55 M2 subunit 55 Bendavia 55 murine monoclonal antibody 55 delipidation 55 VNP#M 55 Phase Ib study 55 immunoregulatory 55 Flt3 55 omacetaxine mepesuccinate 55 vitro cytotoxicity 55 Solorel TM 55 R#/MEM # 55 FVIIa 55 peptide receptor 55 antisense oligonucleotide 55 HER1 55 Pim kinases 55 microtubule inhibitor 55 Cardiotoxicity 55 HuMax 55 AtuRNAi 55 reversible inhibitor 55 Micromet BiTE 55 BNC# 55 Enhanze Technology 55 Alequel TM 55 JAK2 inhibitors 55 Thrombin 55 CXCR4 antagonist 55 topically administered 55 5 HT2A serotonin 55 TLR8 55 STEDESA 55 inhaled AAT 55 dAbs 55 Glycosylation 55 HuLuc# 55 immunostimulatory 55 mitotic kinesin 54 Carfilzomib 54 nanoviricide 54 BAL# [002] 54 Evoltra ® 54 Anticalins 54 GCase 54 EGFR HER2 54 cannabinor 54 SGLT 54 anti CD# antibody 54 Inhalation Solution 54 non nucleoside 54 tumor regressions 54 Corgentin 54 NP2 54 potently inhibit 54 cMET inhibitor 54 maturation inhibitors 54 stated Michelle Berrey 54 GW# [003] 54 PNP inhibitor 54 sd rxRNA 54 telomerase inhibitor 54 Btk Inhibitor 54 Presents Preclinical Data 54 Enkephalin 54 oral renin inhibitor 54 proteasome inhibitor 54 PI3K inhibitor 54 Deforolimus 54 NADiA ProsVue 54 kinase inhibitor 54 PhG alpha 1 54 telomerase activator 54 Pharmacokinetic studies 54 Fibroblast Growth Factor Receptor 54 somatostatin receptor 54 IIa trials 54 IAP inhibitor 54 protein tyrosine phosphatase 1B 54 XOMA 3AB 54 immatics 54 EZN 54 PLA2 54 cMET 54 midstage trials 54 CYT# potent vascular disrupting 54 Pyridorin 54 KSP inhibitors 54 NOD mouse 54 LNP formulations 54 VersaFilm 54 NS5A 54 targeting PCSK9 54 PSN# [001] 54 kinase assay 54 protein tyrosine phosphatase 54 multikinase inhibitor 54 antiproliferative effects 54 nucleoside analog 54 monoclonal antibody mAb 54 JAK3 54 pDNA vaccines 54 retaspimycin 54 Capsulution 54 Interferon Gamma 54 Epothilone 54 Gleevec resistant 54 acetylcholinesterase AChE 54 cathepsin K inhibitor 54 Potent Inhibitor 54 EVIZON ™ 54 Fleximer 54 nicotinic acetylcholine receptor 54 demethylating agent 54 humanised monoclonal antibody 54 Antiangiogenic 54 vosaroxin 54 intranasal formulation 54 hydroxamic acid 54 outlicensed 54 Cyclosert TM 54 antisense oligonucleotides 54 radioprotective 54 Hsp# inhibition 54 Tyrosine Kinase Inhibitors 54 Tß4 54 solubilization 54 Spiegelmer ® 54 Upregulation 54 Anticalin R 54 selective kinase inhibitors 54 stem cell mobilizer 54 inhibitor RG# 54 initiated Phase Ib 54 deforolimus 54 alpha antagonist 54 Virulizin R 54 kinase profiling 54 lorvotuzumab mertansine 54 potent suppressor 54 inhibitor ARRY 54 novel prodrug 54 NN# [001] 54 MET VEGFR2 54 intranasal delivery 54 Chemokine 54 antisense inhibitors 54 recombinant adeno associated 54 Potelligent Technology 54 Pimavanserin 53 TRX1 53 Janus Kinase 53 Cytotoxic 53 VitiGam 53 vivo RNAi 53 Beta catenin pathway 53 cytotoxicity assays 53 Annamycin 53 delafloxacin 53 afamelanotide 53 Tesetaxel 53 haematological cancers 53 NanoEmulsion 53 Camptothecin 53 SYN# 53 AAG geldanamycin analog 53 Sym# 53 protein tyrosine 53 Occlusin TM 53 ® C1 esterase 53 HCD# [002] 53 systemic RNAi therapeutic 53 ALB # 53 ERalpha 53 muscarinic antagonist 53 LEP ETU 53 Enanta 53 huC# DM4 53 Ad5FGF 4 53 PARP Inhibitor 53 cobiprostone 53 DermaVir 53 CBLC# 53 small molecule activator 53 SinuNase ™ 53 ONCONASE R 53 Proteasome 53 novel vascular disrupting 53 Symadex 53 siRNA sequences 53 MAXY VII 53 monoclonal anti 53 TLR9 agonist 53 anti CD# antibodies 53 Biomerk Tumorgrafts 53 selectively inhibited 53 photoprotective drug 53 Thiovir 53 anticancer therapeutics 53 Phase Ib II 53 Clusterin 53 teriflunomide 53 acyclovir Lauriad ® 53 CCR9 antagonist 53 NP2 Enkephalin 53 epoetin alpha 53 nanoviricides 53 Cimzia TM 53 paclitaxel Taxol 53 Qdot 53 erythropoietic 53 TÎ ² 4 53 polyamine 53 TransVax tm 53 Immunotherapeutic 53 glutamyl 53 IND submission 53 Bellicum Pharmaceuticals Inc. 53 benzimidazole 53 adult mesenchymal stem 53 gp# protein [002] 53 oral Azacitidine 53 Preclinical studies indicate 53 elacytarabine 53 GHRH 53 radiotherapeutic 53 potent inducer 53 dacetuzumab 53 cellular cytotoxicity 53 Vivecon 53 lipid nanoparticles 53 PRLX # 53 PARP inhibitor 53 TLK# 53 Talabostat 53 lexidronam injection 53 Nanobody R 53 PDE4 53 Zemplar Capsules 53 UPLYSO 53 glycoprotein GP IIb IIIa 53 galectin 53 cyclin dependent kinase inhibitor 53 ALN TTR 53 GnRH antagonist 53 Tumorgraft 53 iSONEP 53 recombinant biopharmaceutical 53 beta 1a 53 PI3 kinase inhibitor 53 Alzhemed TM 53 annexin V 53 gamma secretase inhibitor 53 BrachySil ™ 53 serine protease inhibitor 53 ERK signaling 53 COPREXA ™ 53 AdhTAP 53 eniluracil 53 Dalbavancin 53 RH1 53 NS3 protease 53 Decitabine 53 M1 muscarinic 53 Tumor Necrosis Factor 53 molecular biomarkers 53 Ultrafast Insulin 53 pharmacophore 53 pharmacodynamic PD 53 NEUGENE 53 phase IIa clinical 53 intradermal injection 53 Stapled Peptide 53 metabolite profiling 53 Mutation Analysis 53 hypoxia activated prodrug 53 Maxy G# 53 proapoptotic 53 antibody humanization 53 parthenolide 53 drug conjugate 53 humanised antibody 53 covalently linked 53 SR# [004] 53 Exherin TM 53 VEGF receptor 53 Sphingomab TM 53 GeneICE 53 Adnectin 53 pharmacokinetic characteristics 53 Glatiramer acetate 53 Oligonucleotide 53 chemoresistant 53 SYGNIS 53 Cinacalcet HCl 53 CEQ# 53 FLT3 53 receptor antagonism 53 ERK activation 52 Tesmilifene 52 thymidine kinase 52 microsomal 52 Qutenza TM 52 #β estradiol 52 IL 1ß 52 2DG 52 plasmid DNA 52 Chemophase 52 vinorelbine tartrate 52 Phase IIA 52 Aurora kinase inhibitor 52 edifoligide E2F Decoy 52 Specifid 52 pain palliation 52 histone acetyltransferase 52 antiproliferative activity 52 Phase #b/#a trial 52 virosome 52 murine model 52 ABL1 52 alvespimycin 52 PROSTVAC VF 52 oral PTH 52 plasmid encoding 52 dendritic cell vaccine 52 geldanamycin 52 SAR# [004] 52 Bellicum 52 imexon 52 HCV nucleoside 52 HSP# inhibitors 52 cellular immunotherapy 52 SPL# 52 LPA1 receptor 52 bevasiranib 52 Junovan TM 52 ASONEP 52 vascular disrupting 52 eIF4E 52 CVac 52 cyclase 52 Cloretazine R 52 prostaglandin synthesis 52 PEGPH# 52 PANVAC VF 52 Belerofon 52 liposomal delivery 52 darinaparsin 52 Safinamide 52 acting inhaled anticholinergic 52 isoenzyme 52 hapten 52 Aplidin R 52 cartilage regeneration 52 #I TM# 52 prolyl 52 trodusquemine 52 IFN α 52 pathway inhibitor 52 Elvitegravir 52 varespladib 52 druggable targets 52 amifampridine phosphate 52 cisplatin resistant 52 dutogliptin 52 systemically administered 52 monoclonal antibody MAb 52 c myc gene 52 steroid sulfatase 52 XTEN 52 RAV# 52 DiLA2 52 TRAIL receptors 52 kinesin spindle protein 52 AKT inhibitor 52 subcutaneous SC 52 auristatin 52 poly ADP ribose polymerase 52 Estrogen Receptor 52 haemostatic 52 Vidaza azacitidine 52 Spiegelmer 52 NK1 52 refractory prostate cancer 52 Fodosine 52 sd rxRNA compounds 52 proteolytic cleavage 52 Morpholino 52 immunoconjugate 52 Protein kinase 52 therapeutic peptide 52 NM# [003] 52 FasL 52 selective estrogen receptor modulator 52 phosphoprotein 52 protein tyrosine kinase 52 diphosphate 52 TransMID 52 Excellagen 52 Pazopanib 52 Antisense 52 PI3K Akt 52 NKX#.# 52 Crystallographic 52 Bioral 52 Kevetrin ™ 52 Androxal TM 52 Shc 52 RNAi Therapeutic 52 radionuclide therapy 52 DURIN TM 52 Assay Kits 52 nucleosides 52 HER2 overexpression 52 novel VDA molecule 52 miRagen 52 Systemic Delivery 52 paclitaxel poliglumex 52 GSK3B 52 BIBW 52 BN# [002] 52 Technosphere ® 52 mutated K ras 52 Bevirimat 52 Hedgehog antagonist 52 sterile lidocaine patch 52 OraTest R 52 pharmacodynamic markers 52 BIM #A# 52 ALK inhibitors 52 brentuximab vedotin SGN 52 prolyl hydroxylase inhibitors 52 activin receptor type 52 MTP inhibitor 52 HuMax TAC 52 AN# novel 52 stent coating 52 rhITF 52 IFN alpha 52 neoplastic transformation 52 Alkaline Phosphatase 52 PathFinderTG 52 motesanib diphosphate 52 methionine aminopeptidase 52 #mg/#mg 52 humoral responses 52 degranulation 52 Glypromate 52 LB# [003] 52 pertuzumab 52 Raf kinase 52 B7 H4 52 SuperAntibody 52 HIV reverse transcriptase 52 lipid nanoparticle 52 induced cytotoxicity 52 murine models 52 oxazolidinone 52 Darusentan 52 osteogenic 52 HepDirect technology 52 Secretase 52 tropism testing 52 plasmid DNA pDNA 52 Aptamer 52 oral talactoferrin 52 SMIP 52 fusion inhibitor 51 Collategene 51 intranasal insulin 51 ALK inhibitor 51 neovascularisation 51 microdroplet based 51 HuMax EGFr 51 glycopeptide 51 selectively inhibiting 51 multiple myeloma MM 51 Fenretinide 51 mineralocorticoid receptor 51 Pharmacodynamic 51 adipogenic 51 PGL# 51 SUTENT ® 51 elotuzumab 51 abluminal 51 Blinatumomab 51 Hedgehog pathway inhibitor 51 PrevOnco ™ 51 multicenter Phase II 51 heterologous 51 solubilizing 51 fluoropyrimidine 51 PNT# 51 binds selectively 51 selectively binds 51 TIMP 1 51 RAPTIVA 51 potent activator 51 cyclophilin inhibitor 51 fibrotic disease 51 Polymerase 51 retaspimycin hydrochloride 51 somatostatin analog 51 LEAPS TM 51 Ceplene TM 51 refractory gastrointestinal stromal 51 kinase pathway 51 cytochrome P 51 Phase Ib clinical 51 pharmacodynamic properties 51 hepatoma 51 antisense molecules 51 IND enabling 51 PDGF receptor 51 topical lotion 51 drug zotarolimus 51 ZYBRESTAT TM 51 ARC# [001] 51 mineralocorticoid 51 cyclic AMP cAMP 51 HTRF 51 nasally delivered 51 AC Immune 51 MoxDuo ® IR 51 immunoregulation 51 Cytochrome P# 51 AmpliChip 51 antagomirs 51 gonadotrophin releasing hormone GnRH 51 CELLECTRA ® 51 Menerba 51 deacetylation 51 preclinical 51 cyclic peptide 51 CELLECTRA R 51 personalized dendritic 51 Phase #/#a 51 abacavir Ziagen 51 NRTI resistance 51 PathHunter 51 affinity purification 51 IgG1 antibody 51 Phase IIb III 51 Dasatinib 51 molecularly targeted therapy 51 Aethlon Hemopurifier R 51 targeted tyrosine kinase 51 Onconova 51 antitrypsin 51 verteporfin 51 KIACTA ™ 51 Iluvien TM 51 dimerization 51 Calmare Therapy Treatment 51 rhMBL 51 Cumulase 51 E#F# 51 nucleolar 51 intracellular accumulation 51 ASONEP TM 51 Posiphen 51 taxane derivative 51 TLR antagonist 51 Universal Flu Vaccine 51 pomalidomide 51 LHRH receptor positive 51 TKB# 51 Arcelis ™ 51 Teysuno 51 NF kappaB activation 51 DUROS 51 Activity Assay 51 receptor blocker 51 riociguat 51 HIF PH inhibitors 51 NMDAR 51 DNA demethylating agent 51 PREOS R 51 Amplimexon 51 CXCR4 receptor 51 Neuropeptide Y 51 PI3 kinase 51 Lymphoseek ® 51 Kirsten Drejer 51 OMAPRO 51 Files IND 51 novel therapeutic antibodies 51 therapeutic monoclonal antibodies 51 Kinase inhibitor 51 OvaRex 51 prophylactic vaccine 51 immunoreactive 51 AVN# [001] 51 MoxDuo R 51 bifunctional 51 IFN g 51 ACOMPLIA R 51 NeuVax 51 outlicensing 51 Capesaris 51 neointimal proliferation 51 Neuradiab 51 replicase 51 novel mTOR inhibitor 51 predictive toxicology 51 LentiVector 51 Convivia TM 51 IFN beta 51 accumulate preferentially 51 tryptase 51 ponatinib 51 AEMD 51 intercellular signaling 51 IMiDs ® compound 51 rFSH 51 microtubule targeting 51 vernakalant hydrochloride 51 constitutively active 51 molecular determinants 51 Dr. Wayne Danter 51 nanomedicines 51 MVA MUC1 IL2 51 Anti angiogenic 51 CardioVascular BioTherapeutics 51 SynCon TM DNA 51 Extracellular Matrix 51 cilengitide 51 TLR antagonists 51 gefitinib Iressa 51 recombinant fusion 51 PAM4 51 EGS# 51 DAVANAT R 51 unresectable inoperable 51 BHT DNA 51 CRACM 51 Prolor 51 Pertuzumab 51 Yondelis ® 51 HTS assay 51 entity NCE 51 Tarmogen 51 molecule binds 51 diagnostic biomarker 51 flow cytometric 51 Inotek 51 Diazyme 51 Hematopoietic 51 AERx iDMS 51 affinity ligands 51 albumin bound paclitaxel 51 CCR5 inhibitor 51 Microsphere 51 tumor necrosis 51 MDS AML 51 P2Y 51 cytidine 51 Vascular Disrupting Agent 51 novel emulsion formulation 51 Parathyroid Hormone 51 PI3 K 51 radiolabeled monoclonal antibody 51 genitourinary cancers 51 flavopiridol 51 PrevOnco 51 Epitope 51 Traficet EN 51 IgM antibody 51 sitaxsentan 51 Protein Expression 51 Eligen R B# 51 Virtual Histology 51 glucokinase activator 51 Tyrosine Kinase Inhibitor 51 Entry Inhibitor 51 VITAL Trial 51 prostanoid 50 Talotrexin 50 adenosine receptor 50 subcutaneous formulation 50 recurrent glioblastoma multiforme 50 Introgen ADVEXIN 50 FUS1 50 CINQUIL 50 vinblastine 50 intratumoral injection 50 HIV integrase inhibitors 50 goserelin 50 IGF1R 50 vivo preclinical 50 phorbol 50 Raf kinase inhibitor 50 luteal 50 ELISA kit 50 pleiotropic 50 BCL2 50 DP VPA 50 balsalazide tablet 50 vivo toxicology 50 Monoclonal 50 1beta 50 talabostat 50 ChronVac C R 50 morpholino 50 leukocyte adhesion 50 siRNA reagents 50 PF # [002] 50 cMet 50 HCV RNA polymerase 50 Histone Deacetylase 50 hydrolase 50 pDNA vaccine 50 PCK# 50 CRAC channel